rs72807627
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014915.3(ANKRD26):c.3972+3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0922 in 1,607,462 control chromosomes in the GnomAD database, including 8,403 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_014915.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD26 | NM_014915.3 | c.3972+3A>G | splice_region_variant, intron_variant | ENST00000376087.5 | NP_055730.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD26 | ENST00000376087.5 | c.3972+3A>G | splice_region_variant, intron_variant | 5 | NM_014915.3 | ENSP00000365255.4 | ||||
ANKRD26 | ENST00000436985.7 | c.3969+3A>G | splice_region_variant, intron_variant | 1 | ENSP00000405112.3 | |||||
ANKRD26 | ENST00000675116.1 | n.*295+3A>G | splice_region_variant, intron_variant | ENSP00000501975.1 | ||||||
ANKRD26 | ENST00000675936.1 | n.387+3A>G | splice_region_variant, intron_variant | ENSP00000502093.1 |
Frequencies
GnomAD3 genomes AF: 0.0929 AC: 14123AN: 152046Hom.: 778 Cov.: 32
GnomAD3 exomes AF: 0.113 AC: 28190AN: 248670Hom.: 2060 AF XY: 0.114 AC XY: 15443AN XY: 134944
GnomAD4 exome AF: 0.0921 AC: 134084AN: 1455298Hom.: 7613 Cov.: 31 AF XY: 0.0934 AC XY: 67616AN XY: 724218
GnomAD4 genome AF: 0.0931 AC: 14159AN: 152164Hom.: 790 Cov.: 32 AF XY: 0.0990 AC XY: 7365AN XY: 74402
ClinVar
Submissions by phenotype
Thrombocytopenia 2 Benign:3
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 21, 2023 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at